REFRACTORY GLIOBLASTOMA
Clinical trials for REFRACTORY GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental CAR t cell cocktail takes on recurrent glioblastoma
Disease control OngoingThis early-phase trial tests whether a special type of immune cell (CAR T cell) that targets a protein found on glioblastoma cells can be safely given along with two immunotherapy drugs (nivolumab and ipilimumab). The study involves 20 adults with recurrent or treatment-resistant…
Matched conditions: REFRACTORY GLIOBLASTOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Engineered immune cells take on Hard-to-Treat brain cancers
Disease control OngoingThis early-stage trial tests a personalized immunotherapy for people with malignant glioma that has returned or not responded to standard treatment. The patient's own T-cells are collected, genetically modified in a lab to recognize and attack glioma cells, and then infused back …
Matched conditions: REFRACTORY GLIOBLASTOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 26, 2026 13:08 UTC